Search Results - "Muntañola, Anna"
-
1
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population
Published in British journal of haematology (01-05-2019)“…Summary The use of immunochemotherapy has improved the outcome of follicular lymphoma (FL). Recently, complete response at 30 months (CR30) has been suggested…”
Get full text
Journal Article -
2
Platelet Antiaggregant Therapy Prevents Venous Thrombosis in Patients with JAK2 V617F Positive Essential Thrombocythemia without Indication of Cytoreductive Treatment
Published in Blood (20-11-2009)“…Abstract 3906 Poster Board III-842 Essential thrombocythemia (ET) patients under the age of 60 years without history of thrombosis are not considered…”
Get full text
Journal Article -
3
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia
Published in Leukemia & lymphoma (03-10-2018)“…Small lymphocytic lymphoma (SLL) is considered as the non-leukemic form of presentation of chronic lymphocytic leukemia (CLL). We have compared the features,…”
Get full text
Journal Article -
4
A randomized phase II study comparing consolidation with a single dose of 90 Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Published in Leukemia & lymphoma (02-01-2022)“…This is a randomized phase-2 trial aimed to compare consolidation vs. maintenance in untreated patients with follicular lymphoma (FL) responding to induction…”
Get full text
Journal Article -
5
A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Published in Leukemia & lymphoma (02-01-2022)“…This is a randomized phase-2 trial aimed to compare consolidation vs. maintenance in untreated patients with follicular lymphoma (FL) responding to induction…”
Get full text
Journal Article -
6
Bortezomib-induced rhabdomyolysis in multiple myeloma
Published in Acta haematologica (01-01-2006)“…Although multiple myeloma (MM) remains an incurable disease, its treatment has improved over the past decade. This improvement has been at least in part due to…”
Get more information
Journal Article -
7
Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases
Published in Blood (06-12-2014)“…MCL is a mature B-cell neoplasm characterized by t(11;14) (q13;q32) and cyclin D1 (CCND1) overexpression. Molecular studies have revealed other alterations in…”
Get full text
Journal Article -
8
A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization
Published in Blood (15-11-2013)“…▪ Patients with FL can have long time of survival, but disease progression typically occurs 3-5 years after initial treatment. Consolidation with Z after…”
Get full text
Journal Article